Search All UT System Experts

The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1 pancreatic cancer cells, causing perturbation in central carbon metabolism

Molly A. Silvers, Stanislaw Deja, Naveen Singh, Robert A. Egnatchik, Jessica Sudderth, Xiuquan Luo, Muhammad S. Beg, Shawn C. Burgess, Ralph J. DeBerardinis, David A. Boothman, Matthew E. Merritt

Research output: Contribution to journal › Article › peer-review

67 Scopus citations

Fingerprint

Dive into the research topics of 'The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1 pancreatic cancer cells, causing perturbation in central carbon metabolism'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences